Richard I. Shader
#84,150
Most Influential Person Now
Researcher
Richard I. Shader's AcademicInfluence.com Rankings
Richard I. Shaderengineering Degrees
Engineering
#1867
World Rank
#2661
Historical Rank
Electrical Engineering
#275
World Rank
#314
Historical Rank
Richard I. Shadercomputer-science Degrees
Computer Science
#2811
World Rank
#2942
Historical Rank
Computational Linguistics
#58
World Rank
#60
Historical Rank
Machine Learning
#209
World Rank
#212
Historical Rank
Artificial Intelligence
#360
World Rank
#367
Historical Rank
Download Badge
Engineering Computer Science
Richard I. Shader's Degrees
- PhD Computer Science Stanford University
- Masters Electrical Engineering University of California, Berkeley
Similar Degrees You Can Earn
Why Is Richard I. Shader Influential?
(Suggest an Edit or Addition)Richard I. Shader's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Drug disposition in old age. (1982) (577)
- Current Status of Benzodiazepines (1983) (403)
- CYP2B6 mediates the in vitro hydroxylation of bupropion: potential drug interactions with other antidepressants. (2000) (396)
- Diazepam disposition determinants (1980) (363)
- Benzodiazepines in Clinical Practice (1974) (335)
- Dose‐Dependent Pharmacokinetics and Psychomotor Effects of Caffeine in Humans (1997) (333)
- A New Scale for Clinical Assessment in Geriatric Populations: Sandoz Clinical Assessment – Geriatric (SCAG) * (1974) (306)
- Protease Inhibitors as Inhibitors of Human Cytochromes P450: High Risk Associated with Ritonavir (1998) (267)
- The dexamethasone suppression test: An overview of its current status in psychiatry (1987) (247)
- Triazolam biotransformation by human liver microsomes in vitro: effects of metabolic inhibitors and clinical confirmation of a predicted interaction with ketoconazole. (1996) (241)
- Sensitivity to triazolam in the elderly. (1991) (241)
- Midazolam Hydroxylation by Human Liver Microsomes In Vitro: Inhibition by Fluoxetine, Norfluoxetine, and by Azole Antifungal Agents (1996) (229)
- Toxicity of high‐dose flurazepam in the elderly (1977) (224)
- Dependence, tolerance, and addiction to benzodiazepines: clinical and pharmacokinetic considerations. (1978) (217)
- Oxazepam kinetics: effects of age and sex. (1980) (214)
- Chronic benzodiazepine administration. I. Tolerance is associated with benzodiazepine receptor downregulation and decreased gamma-aminobutyric acidA receptor function. (1988) (208)
- Escitalopram (S-citalopram) and its metabolites in vitro: cytochromes mediating biotransformation, inhibitory effects, and comparison to R-citalopram. (2001) (205)
- In vitro approaches to predicting drug interactions in vivo. (1998) (205)
- Drug therapy. Current status of benzodiazepines. (1983) (193)
- Midazolam and triazolam biotransformation in mouse and human liver microsomes: relative contribution of CYP3A and CYP2C isoforms. (2000) (186)
- Saint John's wort: An in vitro analysis of P‐glycoprotein induction due to extended exposure (2001) (183)
- Inhibition of alprazolam and desipramine hydroxylation in vitro by paroxetine and fluvoxamine: comparison with other selective serotonin reuptake inhibitor antidepressants. (1995) (183)
- Benzodiazepines: a summary of pharmacokinetic properties. (1981) (174)
- Effect of age and gender on disposition of temazepam. (1981) (170)
- Use of benzodiazepines in anxiety disorders. (1993) (170)
- Inhibition of desipramine hydroxylation in vitro by serotonin-reuptake-inhibitor antidepressants, and by quinidine and ketoconazole: a model system to predict drug interactions in vivo. (1994) (168)
- Clinical Pharmacokinetics of Anxiolytics and Hypnotics in the Elderly (1991) (167)
- Inhibitors of alprazolam metabolism in vitro: effect of serotonin-reuptake-inhibitor antidepressants, ketoconazole and quinidine. (1994) (166)
- O- and N-demethylation of Venlafaxine In Vitro by Human Liver Microsomes and by Microsomes from cDNA-Transfected Cells: Effect of Metabolic Inhibitors and SSRI Antidepressants (1999) (162)
- Drug interactions with newer antidepressants: role of human cytochromes P450. (1998) (160)
- Clinical Pharmacokinetics of Anxiolytics and Hypnotics in the Elderly (2012) (160)
- Reduced benzodiazepine sensitivity in panic disorder. (1990) (157)
- Five Distinct Human Cytochromes Mediate Amitriptyline N‐Demethylation In Vitro: Dominance of CYP 2C19 and 3A4 (1998) (154)
- Pharmacokinetics and Bioavailability of Intravenous, Intramuscular, and Oral Lorazepam in Humans (1979) (152)
- In vitro correlates of benzodiazepine cerebrospinal fluid uptake, pharmacodynamic action and peripheral distribution. (1983) (150)
- Lorazepam kinetics in the elderly (1979) (150)
- Pharmacokinetic and electroencephalographic study of intravenous diazepam, midazolam, and placebo (1989) (146)
- Critical review of liability for benzodiazepine abuse among alcoholics. (1988) (143)
- Kinetics and clinical effects of flurazepam in young and elderly noninsomniacs (1981) (143)
- Zolpidem metabolism in vitro: responsible cytochromes, chemical inhibitors, and in vivo correlations. (1999) (134)
- In vitro biotransformation of sildenafil (Viagra): identification of human cytochromes and potential drug interactions. (2000) (134)
- Imipramine and desipramine disposition in the elderly. (1985) (133)
- Alterations in drug distribution and clearance due to obesity. (1981) (131)
- Ritonavir, efavirenz, and nelfinavir inhibit CYP2B6 activity in vitro: potential drug interactions with bupropion. (2001) (129)
- Impairment of diazepam metabolism by low-dose estrogen-containing oral-contraceptive steroids. (1982) (128)
- Biotransformation of Chlorzoxazone by Heptatic Microsomes from Humans and Ten Other Mammalian Species (1997) (126)
- Metabolism of the antidepressant mirtazapine in vitro: contribution of cytochromes P-450 1A2, 2D6, and 3A4. (2000) (124)
- Clinical Uses of Benzodiazepines (1993) (124)
- Inhibition of Human Cytochrome P450 Isoforms by Nonnucleoside Reverse Transcriptase Inhibitors (2001) (122)
- Ketoconazole inhibition of triazolam and alprazolam clearance: Differential kinetic and dynamic consequences (1998) (121)
- Clinical Pharmacokinetics of the Newer Benzodiazepines (1983) (121)
- Comparative kinetics and response to the benzodiazepine agonists triazolam and zolpidem: evaluation of sex-dependent differences. (2000) (120)
- Alcoholism in women. (1971) (119)
- Rapid increase in brain benzodiazepine receptor binding following defeat stress in mice (1987) (118)
- Trazodone kinetics: Effect of age, gender, and obesity (1987) (118)
- Alprazolam‐ritonavir interaction: Implications for product labeling (2000) (118)
- Acute overdosage with benzodiazepine derivatives (1977) (117)
- Fluoxetine drug-drug interactions: I. Antidepressants and antipsychotics. (1990) (115)
- Metabolism of Drugs by Cytochrome P450 3A Isoforms (1995) (114)
- In Vitro Prediction of the Terfenadine‐Ketoconazole Pharmacokinetic Interaction (1994) (114)
- Burger's Medicinal Chemistry and Drug Discovery: (1995) (112)
- Comparative kinetics and dynamics of zaleplon, zolpidem, and placebo (1998) (112)
- Enhanced glucuronide conjugation of drugs in obesity: studies of lorazepam, oxazepam, and acetaminophen. (1983) (112)
- Phenacetin O-deethylation by human liver microsomes in vitro: inhibition by chemical probes, SSRI antidepressants, nefazodone and venlafaxine (1996) (110)
- Alprazolam kinetics in the elderly. Relation to antipyrine disposition. (1983) (109)
- Antipyrine kinetics in the elderly: prediction of age-related changes in benzodiazepine oxidizing capacity. (1982) (107)
- Alprazolam metabolism in vitro: studies of human, monkey, mouse, and rat liver microsomes. (1993) (103)
- Benzodiazepine kinetics: implications for therapeutics and pharmacogeriatrics. (1983) (103)
- Drug therapy. Benzodiazepines (first of two parts). (1974) (103)
- Absorption and Disposition of Chlordiazepoxide in Young and Elderly Male Volunteers (1977) (103)
- Multiple Human Cytochromes Contribute to Biotransformation of Dextromethorphan In‐vitro: Role of CYP2C9, CYP2C19, CYP2D6, and CYP3A (1998) (101)
- Depression in the Elderly. I. Relationship between Depression, Psychologic Defense Mechanisms and Physical Illness * (1978) (100)
- Kinetic and dynamic study of intravenous lorazepam: comparison with intravenous diazepam. (1989) (99)
- Implications of Altered Drug Disposition in the Elderly: Studies of Benzodiazepines (1989) (98)
- Pharmacokinetics of Diphenhydramine and a Demethylated Metabolite Following Intravenous And Oral Administration (1986) (98)
- Reduced clearance of triazolam in old age: relation to antipyrine oxidizing capacity. (1983) (97)
- Benzodiazepine receptor occupancy in vivo: correlation with brain concentrations and pharmacodynamic actions. (1987) (96)
- Absolute Bioavailability of Oral and Intramuscular Diazepam: Effects of Age and Sex (1983) (96)
- N-demethylation of amitriptyline in vitro: role of cytochrome P-450 3A (CYP3A) isoforms and effect of metabolic inhibitors. (1995) (95)
- Inhibition of CYP2C9 by selective serotonin reuptake inhibitors in vitro: studies of phenytoin p-hydroxylation. (2003) (95)
- Pharmacokinetic properties of zolpidem in elderly and young adults: possible modulation by testosterone in men. (2003) (95)
- Clinical Importance of the Interaction of Diazepam and Cimetidine (1984) (93)
- Human cytochromes and some newer antidepressants: kinetics, metabolism, and drug interactions. (1999) (93)
- Inhibition of triazolam clearance by macrolide antimicrobial agents: In vitro correlates and dynamic consequences (1998) (93)
- On the psychopharmacology of beta adrenergic blockade. (1972) (92)
- Clinical pharmacokinetics of lorazepam (1976) (92)
- Differential effect of cimetidine on drug oxidation (antipyrine and diazepam) vs. conjugation (acetaminophen and lorazepam): prevention of acetaminophen toxicity by cimetidine. (1983) (91)
- Electron-capture gas chromatographic analysis of the triazolobenzodiazepines alprazolam and triazolam. (1981) (91)
- Effect of gradual withdrawal on the rebound sleep disorder after discontinuation of triazolam. (1987) (91)
- In vitro quantitation of benzodiazepine lipophilicity: relation to in vivo distribution. (1983) (89)
- Desmethyldiazepam kinetics in the elderly after oral prazepam (1980) (87)
- Probenecid impairment of acetaminophen and lorazepam clearance: direct inhibition of ether glucuronide formation. (1985) (86)
- Pharmacokinetic Comparison of Sublingual Lorazepam with Intravenous, Intramuscular, and Oral Lorazepam (1982) (84)
- Citalopram and desmethylcitalopram in vitro: human cytochromes mediating transformation, and cytochrome inhibitory effects (1999) (84)
- Chronic benzodiazepine administration. II. Discontinuation syndrome is associated with upregulation of gamma-aminobutyric acidA receptor complex binding and function. (1988) (84)
- Rapid recovery from massive diazepam overdose. (1978) (84)
- Inhibition of terfenadine metabolism in vitro by azole antifungal agents and by selective serotonin reuptake inhibitor antidepressants: relation to pharmacokinetic interactions in vivo. (1996) (83)
- Psychotropic drug use in the Boston area. A report from the Boston Collaborative Drug Surveillance Program. (1975) (83)
- Diazepam absorption: Effect of antacids and food (1978) (82)
- COVID-19 and Depression (2020) (82)
- Differential actions of chlordiazepoxide and oxazepam on hostility. (1968) (81)
- Age and gender effects on the pharmacokinetics and pharmacodynamics of triazolam, a cytochrome P450 3A substrate (2004) (80)
- Phenelzine and the dream machine--ramblings and reflections. (1985) (80)
- Plasma diazepam and desmethyldiazepam concentrations during long-term diazepam therapy. (1981) (80)
- Pharmacokinetic determinants of dynamic differences among three benzodiazepine hypnotics. Flurazepam, temazepam, and triazolam. (1989) (79)
- Nefazodone, meta-chlorophenylpiperazine, and their metabolites in vitro: cytochromes mediating transformation, and P450-3A4 inhibitory actions (1999) (79)
- Human cytochromes mediating N-demethylation of fluoxetine in vitro (1997) (78)
- Clobazam kinetics in the elderly. (1981) (77)
- Inhibition of desipramine hydroxylation (Cytochrome P450-2D6) in vitro by quinidine and by viral protease inhibitors: relation to drug interactions in vivo. (1998) (76)
- Does carbamazepine-induced reduction of plasma haloperidol levels worsen psychotic symptoms? (1986) (76)
- Prolonged Accumulation of Diazepam in Obesity (1983) (76)
- Abuse liability and clinical pharmacokinetics of alprazolam in alcoholic men. (1988) (75)
- Chlordiazepoxide-induced hostility in a small group setting. (1974) (74)
- Absorption rate, blood concentrations, and early response to oral chlordiazepoxide. (1977) (73)
- Clinical pharmacokinetics of lorazepam: a review. (1978) (71)
- Pharmacokinetics and bioavailability of intravenous, intramuscular, and oral lorazepam in humans. (1980) (70)
- Impaired absorption of desmethyldiazepam from clorazepate by magnesium aluminum hydroxide (1978) (70)
- Comparative single‐dose kinetics and dynamics of lorazepam, alprazolam, prazepam, and placebo (1988) (69)
- Analysis of lorazepam and its glucoronide metabolite by electron-capture gas—liquid chromatography (1978) (69)
- Fluoxetine drug-drug interactions. II. (1990) (69)
- Clinical implications of benzodiazepine pharmacokinetics. (1977) (68)
- Drug therapy. Anticholinergics. (1973) (68)
- Kinetic and dynamic interaction study of zolpidem with ketoconazole, itraconazole, and fluconazole (1998) (68)
- Long v short half-life benzodiazepines in the elderly. Kinetics and clinical effects of diazepam and oxazepam. (1983) (66)
- Absorption and disposition of ibuprofen in the elderly. (1984) (64)
- Extensive impairment of triazolam and alprazolam clearance by short-term low-dose ritonavir: the clinical dilemma of concurrent inhibition and induction. (1999) (63)
- Clinical Pharmacokinetics of Chlordiazepoxide (1975) (62)
- Relative Contribution of CYP3A to Amitriptyline Clearance in Humans: In Vitro and In Vivo Studies (2001) (62)
- Drug therapy: drug disposition in old age. (1982) (61)
- Short‐Term Exposure to Low‐Dose Ritonavir Impairs Clearance and Enhances Adverse Effects of Trazodone (2003) (61)
- Drug interactions with grapefruit juice: an update. (2001) (60)
- A Controlled Study of the Effects of State Surveillance on Indicators of Problematic and Non-Problematic Benzodiazepine Use in a Medicaid Population (2004) (60)
- Parental alcoholism as a risk factor in benzodiazepine abuse: a pilot study. (1989) (59)
- Analysis of lorazepam and its glucuronide metabolite by electron-capture gas--liquid chromatography. Use in pharmacokinetic studies of lorazepam. (1978) (58)
- Relationship of plasma and brain concentrations of caffeine and metabolites to benzodiazepine receptor binding and locomotor activity. (1989) (58)
- Repeated diazepam dosing in cirrhotic patients: Cumulation and sedation (1983) (56)
- Pharmacokinetics in clinical practice (1985) (56)
- Chronic benzodiazepine administration. IV. Rapid development of tolerance and receptor downregulation associated with alprazolam administration. (1989) (56)
- Inhibition of Human Cytochrome P450‐3A Isoforms by Fluoxetine and Norfluoxetine: In Vitro and In Vivo Studies (1996) (56)
- Schizophrenia: pharmacotherapy and psychotherapy (1972) (55)
- Population study of triazolam pharmacokinetics. (1986) (55)
- Triazolam and anterograde amnesia: all is not well in the Z-zone. (1983) (54)
- Bromazepam pharmacokinetics: Influence of age, gender, oral contraceptives, cimetidine, and propranolol (1987) (54)
- Influence of magnesium and aluminum hydroxide mixture on chlordiazepoxide absorption (1976) (54)
- Lethality and Behavioral Side Effects of Chloroquine (1982) (53)
- Prolongation of drug half-life due to obesity: studies of desmethyldiazepam (clorazepate). (1982) (53)
- Relationship of in vitro data on drug metabolism to in vivo pharmacokinetics and drug interactions: implications for diazepam disposition in humans. (1996) (53)
- CYP3A4 is the major CYP isoform mediating the in vitro hydroxylation and demethylation of flunitrazepam. (2001) (53)
- Possible Interaction between Fluoxetine and Pimozide Causing Sinus Bradycardia (1993) (53)
- Kinetic and dynamic components of increased benzodiazepine sensitivity in aging animals. (1990) (52)
- Lorazepam and oxazepam kinetics in women on low‐dose oral contraceptives (1983) (52)
- The use of benzodiazepines for psychotic disorders: a literature review and preliminary clinical findings. (1986) (52)
- Characterization of six in vitro reactions mediated by human cytochrome P450: application to the testing of cytochrome P450-directed antibodies. (1996) (52)
- Pharmacokinetic aspects of drug therapy in the elderly. (1986) (52)
- Interaction of caffeine with the GABAA receptor complex: alterations in receptor function but not ligand binding. (1989) (51)
- From Disordered Eating to Addiction: The “Food Drug” in Bulimia Nervosa (2012) (51)
- In vitro metabolism of trazodone by CYP3A: inhibition by ketoconazole and human immunodeficiency viral protease inhibitors (2000) (51)
- Psychiatric Complications of Medical Drugs (1972) (51)
- Clonazepam pharmacokinetics, brain uptake, and receptor interactions. (1987) (51)
- Kinetic Characterization and Identification of the Enzymes Responsible for the Hepatic Biotransformation of Adinazolam and N‐Desmethyladinazolam in Man (1998) (49)
- Prazepam and lorazepam, two new benzodiazepines. (1978) (49)
- Clinical pharmacokinetics of lorazepam; II. Intramuscular injection (1977) (49)
- Kinetics of intravenous chlordiazepoxide: Sex differences in drug distribution (1977) (48)
- Patterns of violent behavior among schizophrenic inpatients. (1977) (48)
- The clinician and drug interactions--an update. (1996) (48)
- Panic Disorders: Current Perspectives (1982) (48)
- Alprazolam pharmacokinetics, metabolism, and plasma levels: clinical implications. (1993) (48)
- Enhanced Bioavailability of Triazolam Following Sublingual Versus Oral Administration (1986) (48)
- Psychotropic drug side effects : clinical and theoretical perspectives (1971) (48)
- Psychotherapy and pharmacotherapy in chronic schizophrenia. (1968) (47)
- Enzyme kinetic modelling as a tool to analyse the behaviour of cytochrome P450 catalysed reactions: application to amitriptyline N-demethylation. (2003) (47)
- Pharmacokinetics and Pharmacodynamics of Diphenhydramine 25 mg in Young and Elderly Volunteers (1998) (46)
- Interaction of propoxyphene with diazepam, alprazolam and lorazepam. (1985) (45)
- Appropriate Use and Regulatory Control of Benzodiazepines (1991) (45)
- 'GABA shift' in vivo: enhancement of benzodiazepine binding in vivo by modulation of endogenous GABA. (1988) (45)
- Caffeine-induced behavioral stimulation is dose-dependent and associated with A1 adenosine receptor occupancy. (1992) (45)
- Clobazam Kinetics: Intrasubject Variability and Effect of Food on Absorption (1982) (45)
- Alprazolam is another substrate for human cytochrome P450-3A isoforms. (1998) (45)
- Behavioral toxicity and equivocal suicide associated with chloroquine and its derivatives. (1977) (44)
- Fatal hyperthermia following haloperidol therapy of sedative-hypnotic withdrawal. (1978) (44)
- Neurochemical and pharmacokinetic correlates of the clinical action of benzodiazepine hypnotic drugs. (1990) (44)
- Long-term administration of benzodiazepines: pharmacokinetic versus pharmacodynamic tolerance. (1986) (43)
- Flurazepam hydrochloride, a benzodiazepine hypnotic. (1975) (43)
- Slow absorption of intramuscular chlordiazepoxide. (1974) (43)
- Oxaprozin pharmacokinetics in the elderly. (1985) (43)
- Sedative effects and impaired learning and recall after single oral doses of lorazepam (1986) (43)
- Langner's Psychiatric Impairment Scale: a short screening device. (1971) (43)
- Cytochromes in psychopharmacology. (1994) (43)
- Benzodiazepine hypnotics: kinetic and therapeutic options. (1982) (43)
- Inhibition of cytochrome P450 by nefazodone in vitro: studies of dextromethorphan O- and N-demethylation. (2003) (43)
- Chronic benzodiazepine administration (1991) (43)
- Uses and toxicity of belladonna alkaloids and synthetic anticholinergics. (1971) (43)
- Pharmacokinetic comparison of sublingual lorazepam with intravenous, intramuscular, and oral lorazepam. (1983) (42)
- Clinical Pharmacokinetics of the Benzodiazepines (1985) (42)
- The pharmacokinetics of diazepam and desmethyldiazepam in rat brain and plasma (1986) (42)
- Influence of age, gender, and obesity on salicylate kinetics following single doses of aspirin. (1986) (41)
- Alprazolam-induced mania: two clinical cases. (1985) (41)
- Marijuana and hostility in a small-group setting. (1976) (40)
- Extrapolating in vitro data on drug metabolism to in vivo pharmacokinetics: evaluation of the pharmacokinetic interaction between amitriptyline and fluoxetine. (1999) (40)
- Plasma haloperidol levels drawn at neuroleptic threshold doses: a pilot study. (1986) (39)
- Cimetidine Impairs Clearance of Antipyrine and Desmethyldiazepam in the Elderly (1982) (39)
- Desmethyldiazepam Pharmacokinetics: Studies Following Intravenous and Oral Desmethyldiazepam, Oral Clorazepate, and Intravenous Diazepam (1988) (39)
- Drug therapy. Benzodiazepines (second of two parts). (1974) (39)
- The Neuropsychiatric Effects of Aspartame in Normal Volunteers (1990) (39)
- Psychotropic drugs and induced hostility. (1969) (39)
- Diagnosis and Drug Treatment of Psychiatric Disorders: Adults and Children (1982) (39)
- Cognitive effects of β‐adrenergic antagonists after single doses: Pharmacokinetics and pharmacodynamics of propranolol, atenolol, lorazepam, and placebo (1993) (39)
- Imipramine-cimetidine interaction: impairment of clearance and enhanced absolute bioavailability. (1984) (39)
- Factors influencing diazepam pharmacokinetics: age, sex, and liver disease. (1978) (38)
- Effects of age and other drugs on benzodiazepine kinetics. (1980) (38)
- Human cytochromes mediating sertraline biotransformation: seeking attribution. (1999) (38)
- The differential effects of chlordiazepoxide and oxazepam on hostility in a small group setting. (1975) (38)
- Automated gas chromatographic determination of plasma alprazolam concentrations. (1983) (38)
- Bees, ginseng and MAOIs revisited. (1988) (38)
- Drug administration schedules. (1969) (37)
- Adverse interactions encountered when using trazodone to treat insomnia associated with fluoxetine. (1990) (37)
- Clinical pharmacokinetics of lorazepam. I. Absorption and disposition of oral 14C-lorazepam. (1976) (37)
- Fluoxetine inhibition of phenytoin metabolism. (1994) (37)
- Preliminary evidence of benzodiazepine subsensitivity in panic disorder (1989) (36)
- The effect of benztropine on haloperidol-induced dystonia, clinical efficacy and pharmacokinetics: a prospective, double-blind trial. (1991) (36)
- Pharmacokinetic Understanding of Antianxiety Drug Therapy (1978) (36)
- Benzodiazepine Receptor Binding of Triazolobenzodiazepines In Vivo: Increased Receptor Number with Low‐Dose Alprazolam (1987) (36)
- Metabolism of haloperidol: clinical implications and unanswered questions. (1994) (36)
- Psychotropic drug prescribing in the United States: extent, costs, and expenditures. (2011) (36)
- SEXUAL DYSFUNCTION ASSOCIATED WITH THIORIDAZINE HYDROCHLORIDE. (1964) (36)
- Management of anxiety in the elderly: the balance between therapeutic and adverse effects. (1982) (35)
- Pharmacokinetics of alprazolam. (1983) (35)
- Clinical Pharmacokinetics of Antidepressants in the Elderly (1993) (35)
- Biotransformation of Mestranol to Ethinyl Estradiol In Vitro: The Role of Cytochrome P‐450 2C9 and Metabolic Inhibitors (1997) (35)
- Clinical Pharmacokinetics of Lorazepam. III. Intravenous Injection. Preliminary Results (1977) (34)
- Plasma alprazolam concentrations. Relation to efficacy and side effects in the treatment of panic disorder. (1993) (34)
- Effects of ketoconazole on triazolam pharmacokinetics, pharmacodynamics and benzodiazepine receptor binding in mice. (1998) (34)
- Chronic benzodiazepine administration. VI. A partial agonist produces behavioral effects without tolerance or receptor alterations. (1990) (33)
- Adverse reactions to triazolam, flurazepam, and placebo in controlled clinical trials. (1984) (33)
- Age and gender effects on chlordiazepoxide kinetics: relation to antipyrine disposition. (1989) (33)
- Interaction of Diazepam With Famotidine and Cimetidine, Two H2‐Receptor Antagonists (1986) (32)
- Reduced Single-dose Clearance of Clobazam in Elderly Men Predicts Increased Multiple-dose Accumulation (1983) (32)
- Pharmocokinetics and pharmacodynamics of single-dose triazolam: electroencephalography compared with the Digit-Symbol Substitution Test. (2005) (32)
- Physostigmine test in the rabbit syndrome and tardive dyskinesia. (1980) (32)
- Effect of age, body composition, and lipid solubility on benzodiazepine tissue distribution in rats. (1987) (32)
- Meprobamate: a study of irrational drug use. (1971) (32)
- Benzodiazepine discontinuation syndromes. (1990) (31)
- Single‐Dose Pharmacokinetics and Pharmacodynamics of Alprazolam in Elderly and Young Subjects (1998) (31)
- Pharmacokinetics of Benzodiazepines and Psychostimulants in Children (1983) (31)
- Rating scales for geriatric psychopharmacology--a review. (1972) (30)
- Suppression of norepinephrine appearance rate in plasma by diazepam in humans. (1988) (30)
- Absence of Interaction of Cimetidine and Ranitidine with Intravenous and Oral Midazolam (1986) (30)
- Serotonin in Affective Disorders: Anatomic, Pharmacologic, and Clinical Perspectives, a Symposium (1987) (30)
- Alprazolam Pharmacokinetics in Women on Low‐Dose Oral Contraceptives (1988) (29)
- A retrospective study of children's perceptions of participation as clinical research subjects in a minimal risk study. (2001) (29)
- Update on Psychotropic Drug Prescribing in the United States: 2014-2015. (2017) (29)
- The Clinical Choice of Sedative-Hypnotics (1972) (28)
- Venlafaxine and metabolites are very weak inhibitors of human cytochrome P450-3A isoforms (1997) (28)
- Chronic administration of benzodiazepines—V. Rapid onset of behavioral and neurochemical alterations after discontinuation of alprazolam (1990) (28)
- Antipyrine absorption and disposition in the elderly. (1988) (28)
- Effects of age on in vitro midazolam biotransformation in male CD-1 mouse liver microsomes. (2000) (28)
- Low-dose alprazolam augments motor activity in mice (1988) (28)
- Pharmacokinetic properties of benzodiazepine hypnotics. (1983) (27)
- Liability to alprazolam abuse in daughters of alcoholics. (1996) (26)
- Combination of fluoxetine with pemoline in the treatment of major depressive disorder. (1991) (26)
- Pharmacokinetics of benzodiazepine hypnotics. (1982) (26)
- International Task Force on Benzodiazepines (2018) (26)
- Pharmacodynamic and receptor binding changes during chronic lorazepam administration (2001) (26)
- Prenatal exposure to benzodiazepine—I. Prenatal exposure to lorazepam in mice alters open-field activity and GABAA receptor function (1991) (26)
- Pharmacokinetics in clinical medicine: oxazepam versus other benzodiazepines. (1975) (26)
- COVID-19 Vaccine Effectiveness (2021) (25)
- Kinetics and EEG Effects of Midazolam during and after 1‐Minute, 1‐Hour, and 3‐Hour Intravenous Infusions (2004) (25)
- Chronic benzodiazepine administration. III. Upregulation of gamma-aminobutyric acidA receptor binding and function associated with chronic benzodiazepine antagonist administration. (1989) (25)
- Dr. Ciraulo and Associates Reply (1989) (25)
- Alprazolam Kinetics Following Sublingual and Oral Administration (1987) (25)
- Benzodiazepines: it's time to return to the evidence (2020) (25)
- Treatment of diazepam withdrawal syndrome with propranolol. (1981) (25)
- Biasing factors in diagnosis and disposition. (1969) (25)
- Clinical manual of chemical dependence (1991) (25)
- Gas chromatographic analysis of alprazolam in plasma: replicability, stability and specificity. (1990) (24)
- Interaction of triazolam and ketoconazole (1995) (24)
- Effect of age and Billroth gastrectomy on absorption of desmethyldiazepam from clorazepate (1979) (24)
- Inhibition of Triazolam Hydroxylation by Ketoconazole, Itraconazole, Hydroxyitraconazole and Fluconazole In‐vitro (1998) (24)
- Tissue Distribution of Diazepam and Its Metabolite Desmethyldiazepam: A Human Autopsy Study (1985) (23)
- Antagonists, inverse agonists, and protagonists. (2003) (23)
- Ranitidine does not impair oxidative or conjugative metabolism: Noninteraction with antipyrine, diazepam, and lorazepam (1984) (23)
- Triazolam Kinetics: Interaction with Cimetidine, Propranolol, and the Combination (1988) (23)
- Manual of Psychiatric Therapeutics (1994) (23)
- Modification of γ‐Aminobutyric AcidA Receptor Binding and Function by N‐Ethoxycarbonyl‐2‐Ethoxy‐1,2‐Dihydroquinoline In Vitro and In Vivo: Effects of Aging (1991) (23)
- In vitro biotransformation of sildenafil (Viagra) in the male rat: the role of CYP2C11. (2002) (23)
- Kinetic and dynamic interaction of brotizolam and ethanol. (1986) (23)
- Noninteraction of temazepam and cimetidine. (1984) (23)
- Inhibition of human cytochrome P450 isoforms in vitro by zafirlukast (1999) (23)
- Meditation and Mindfulness. (2017) (23)
- The use of benzodiazepines in clinical practice. (1981) (22)
- Tricyclic antidepressant determination in human plasma by gas-liquid chromatography using nitrogen-phosphorous detection: application to single-dose pharmacokinetic studies. (1981) (22)
- Newer antidepressants: hypotheses and evidence. (1997) (22)
- Chronic benzodiazepine administration (2005) (22)
- Case 2: Behavioral changes with temporal lobe epilepsy: assessment and treatment. (1980) (22)
- Changes in cognition, attention and language in acute schizophrenia. (1969) (22)
- Interaction of Cimetidine with Oxazepam, Lorazepam, and Flurazepam (1984) (22)
- Zolpidem Pharmacokinetic Properties in Young Females: Influence of Smoking and Oral Contraceptive Use (2002) (21)
- Gepirone and 1-(2-pyrimidinyl)-piperazine in vitro: human cytochromes mediating transformation and cytochrome inhibitory effects (1998) (21)
- Clinical Pharmacology and Therapeutics of Antidepressants (2004) (21)
- A Proposal for a Model Psychopharmacology Curriculum for Psychiatric Residents (1993) (21)
- Selective serotonin reuptake inhibitors and benzodiazepines in panic disorder: A meta-analysis of common side effects in acute treatment (2019) (21)
- The effects of antianxiety and antipsychotic drugs and sexual behavior. (1980) (21)
- Drug abuse and the emergency room physician. (1974) (20)
- Differential modulation of benzodiazepine receptor binding by ethanol in LS and SS mice (1988) (20)
- Multiple complications and death following protriptyline overdose. (1974) (20)
- Contraceptive effectiveness: cytochromes and induction. (2000) (20)
- Hyperforin Plasma Level as a Marker of Treatment Adherence in the National Institutes of Health Hypericum Depression Trial (2005) (20)
- Benzodiazepine drug-drug interactions commonly occurring in clinical practice. (1984) (19)
- Potassium, antipsychotic agents, arrhythmias, and sudden death. (1998) (19)
- Behavioral toxicity of psychotropic drugs. I. Definition. II. Toxic effects on psychomotor functions. (1968) (19)
- Plasma concentrations and clinical effects after single oral doses of prazepam, clorazepate, and diazepam. (1984) (19)
- Clearance of the Antihistamine Doxylamine (1989) (19)
- The pharmacokinetics and pharmacodynamics of sublingual and oral alprazolam in the post-prandial state (1992) (19)
- Clozapine and fluvoxamine, a curious complexity. (1998) (19)
- Depression in the Elderly. II. Possible Drug Etiologies; Differential Diagnostic Criteria * (1978) (19)
- Effects of chlordiazepoxide and oxazepam administration on verbal hostility. (1977) (19)
- Pharmacokinetics of intravenous caffeine: comparison of high-performance liquid chromatographic and gas chromatographic methods. (1987) (19)
- Sandoz Clinical Assessment-Geriatric (SCAG). (1988) (19)
- Interaction of cimetidine with the triazolobenzodiazepines alprazolam and triazolam (1983) (18)
- Psychopharmacologic Investigations in Healthy Elderly Volunteers: MMPI Depression Scale † (1975) (18)
- The therapist variable. (1971) (18)
- Kinetics, brain uptake, and receptor binding characteristics of flurazepam and its metabolites (1988) (18)
- Clinical handbook of psychopharmacology (1970) (18)
- Sex differences in diazepam protein binding in patients with renal insufficiency. (1978) (18)
- Alumni of the Massachusetts mental health center residency training. (1976) (17)
- The Prescription of Benzodiazepines for Panic Disorder: Time for an Evidence-Based Educational Approach. (2018) (17)
- Pharmacokinetic noninteraction of triazolam and ethanol. (1984) (17)
- Pharmacotherapy of Depression (2004) (17)
- Serum Creatine Phosphokinase Concentrations After Intramuscular Chlordiazepoxide and Its Solvent (1976) (17)
- Benzodiazepines: Safety and toxicity. (1975) (16)
- Impairment of hepatic drug oxidation by propoxyphene. (1982) (16)
- Serum creatine phosphokinase and aldolase activity in acute schizophrenic patients and their relatives. (1970) (16)
- Benzodiazepine overdosage: Plasma concentrations and clinical outcome (2004) (16)
- The effect of age on sildenafil biotransformation in rat and mouse liver microsomes. (2003) (16)
- Clearance of the antihistamine doxylamine. Reduced in elderly men but not in elderly women. (1989) (16)
- Liquid chromatographic determination of chlordiazepoxide and metabolites in plasma. (1982) (16)
- The dexamethasone suppression index: enhancement of DST diagnostic utility for depression by expressing serum cortisol as a function of serum dexamethasone. (1988) (16)
- Benzodiazepine use and risk for Alzheimer disease. (2015) (16)
- Interviewer anger and patient dropout in walk-in clinic. (1970) (15)
- Correlates of outcome following acute glutethimide overdosage. (1979) (15)
- Bioinequivalence of a generic brand of diazepam. (1989) (15)
- The diagnosis and treatment of panic disorder in alcoholics: three cases. (1990) (15)
- Differences in pharmacodynamics but not pharmacokinetics between subjects with panic disorder and healthy subjects after treatment with a single dose of alprazolam. (2000) (15)
- Absorption of oral and intramuscular chlordiazepoxide (1978) (14)
- Long-term treatment of chronic schizophrenia. A preliminary report. (1967) (14)
- Plasma levels of trazodone: methodology and applications. (1984) (14)
- Nursing Staff Attitudes and the Clinical Course of Psychotic Patients (1966) (14)
- Kinetics and dynamics of single doses of oxazepam in the elderly: implications of absorption rate. (1986) (14)
- Pharmacokinetic study of lorazepam overdosage. (1980) (14)
- Flurazepam hydrochloride (1975) (14)
- Single‐Dose Kinetics of Prazepam, a Precursor of Desmethyldiazepam (1979) (14)
- The reappearance of a monamine oxidase inhibitor (isocarboxazid) (1999) (14)
- Obesity effects on nitrazepam disposition. (1986) (14)
- Effect of a cocktail on diazepam absorption (1978) (14)
- Haloperidol determination in serum and cerebrospinal fluid using gas--liquid chromatography with nitrogen--phosphorus detection: application to pharmacokinetic studies. (1984) (14)
- Absolute bioavailability of imipramine: Influence of food (2004) (14)
- Cocaine augments peripheral benzodiazepine binding in humans. (1990) (13)
- SLOW ABSORPTION OF INTRAMUSCULAR CHLORDIAZEPOXIDE (1975) (13)
- Chronic benzodiazepine administration. X. Concurrent administration of the peripheral-type benzodiazepine ligand PK11195 attenuates chronic effects of lorazepam. (1992) (13)
- Proof of Feasibility: What a Pilot Study Is and Is Not. (2015) (13)
- COVID-19, interferons, and depression: A commentary (2020) (13)
- Chronic benzodiazepine administration. IX. Attenuation of alprazolam discontinuation effects by carbamazepine. (1991) (13)
- Haloperidol Update: 1958-1980 (1981) (13)
- Augmentation of GABAA receptor function by chronic exposure to GABA-neutral and GABA-negative benzodiazepine ligands in cultured cortical neurons. (1990) (13)
- BEHAVIOURAL REACTIONS TO TRIAZOLAM (1979) (13)
- Benzodiazepines: some aspects of their clinical pharmacology. (2008) (13)
- The National Depressive and Manic Depressive Association Versus the Wimp (1986) (13)
- Word frequency measures of verbal disorders in schizophrenia. (1969) (13)
- PRAZEPAM, A PRECURSOR OF DESMETHYLDIAZEPAM (1978) (13)
- SOCIAL FIELD EVENTS DURING THE FIRST WEEK OF HOSPITALIZATION AS PREDICTORS OF TREATMENT OUTCOME FOR PSYCHOTIC PATIENTS (1967) (12)
- Clinical pharmacokinetics of lorazepam. III. Intravenous injection. Preliminary results. (1978) (12)
- Chronic Benzodiazepine Administration XI Concurrent Administration of PK11195 Attenuates Lorazepam Discontinuation Effects (1993) (12)
- Lorazepam Attenuates the Behavioral Effects of Dizocilpine (1999) (12)
- Some Reflections on IBM Watson and on Women's Health. (2016) (12)
- Appetite suppressant drugs as inhibitors of human cytochromes P450: in vitro inhibition of P450-2D6 by D- and L-fenfluramine, but not phentermine. (1998) (12)
- Central nervous system drug development, basic, and clinical research: thinking outside the box. (2011) (12)
- Twice may be too many: redundant publications. (1996) (12)
- Single- and multiple-dose kinetics of oral lorazepam in humans: The predictability of accumulation (1979) (12)
- Clinical psychopharmacology and the elderly patient. (1976) (12)
- Cardiac side effects and sudden death in hospitalized psychiatric patients. (1977) (12)
- The rise and fall and rise of benzodiazepines: a return of the stigmatized and repressed (2020) (12)
- Not Again: Benzodiazepines Once More Under Attack. (2015) (11)
- Guidelines for the withdrawal of narcotic and general depressant drugs. (1973) (11)
- Looking Back and Looking Forward (2005) (11)
- Alprazolam hydroxylation by mouse liver microsomes in vitro: the effect of age and phenobarbital induction. (1997) (11)
- Pilot pharmacokinetic study of brotizolam, a thienodiazepine hypnotic, using electron-capture gas-liquid chromatography. (1983) (11)
- SOCIAL ROLE PERFORMANCE AND PSYCHOPATHOLOGY AMONG RECENTLY HOSPITALIZED AND NONHOSPITALIZED MOTHERS: II. Correlates with Life, Stress and Self‐Reported Psychopathology (1974) (11)
- Behavioral toxicity of psychotropic drugs. 3. Effects on perceptual and cognitive functions. IV. Effects on emotional (mood) states. (1968) (11)
- Clinical pharmacokinetics of antidepressants in the elderly. Therapeutic implications. (1993) (10)
- Acute barbiturate administration increases benzodiazepine receptor binding in vivo (2004) (10)
- Marihuana users and nonusers. Personality test differences. (1972) (10)
- Effect of age and sex on disposition of desmethyldiazepam formed from its precursor clorazepate (2004) (10)
- Phase I trials. (2014) (10)
- Accidental poisoning with psychotropic drugs in children. (1976) (10)
- Can you provide a table of equivalences for benzodiazepines and other marketed benzodiazepine receptor agonists? (1997) (10)
- Long v short half-life benzodiazepines in the elderly???kinetics and clinical effects of diazepam and oxazepam (1983) (10)
- Characterological anxiety levels and premenstrual libido changes. (1968) (10)
- Clinical use of the benzodiazepines. (1981) (10)
- Non‐Neurological Side‐Effects of Antipsychotic Drugs (2007) (10)
- Difficulties in the clinical diagnosis of lithium toxicity. (1979) (10)
- Screening for aminoacidurias in psychiatric inpatients. (1969) (10)
- Cytochromes: a primer for child and adolescent psychiatrists. (1998) (10)
- More on oral contraceptives, drug interactions, herbal medicines, and hormone replacement therapy. (2000) (10)
- Kinetics of oxazepam and lorazepam in two subjects with Gilbert syndrome. (1981) (10)
- The effect of marijuana on small group process. (1977) (9)
- Correlating pharmacokinetics and pharmacodynamics of benzodiazepines: problems and assumptions. (1987) (9)
- Benzodiazepine Treatment of Specific Anxiety States (1981) (9)
- Pharmacokinetics of chlordiazepoxide and metabolites following single and multiple oral doses. (1978) (9)
- Lithium and marijuana. (1981) (9)
- Dose dumping and the dumping of doses. (2007) (9)
- Safety Versus Tolerability. (2018) (9)
- PHENOBARBITAL AND ATROPINE IN COMBINATION, AN ACTIVE CONTROL SUBSTANCE FOR PHENOTHIAZINE RESEARCH. (1964) (9)
- Problems with Drug Interactions in Treating Brain Disorders (1978) (9)
- Demoralization revisited. (2005) (9)
- Response of the elderly to psychotrophic drugs: predictable or idiosyncratic? (1975) (9)
- Interrelationships between regulation of thyroid gland function and psychosis. (1966) (9)
- Schizophrenia, oligospermia, and the phenothiazines. (1967) (9)
- QUESTION THE EXPERTS (1986) (9)
- Clinical pharmacokinetics of chlordiazepoxide. (1978) (9)
- HALAZEPAM, ANOTHER PRECURSOR OF DESMETHYLDIAZEPAM (1982) (8)
- Methadone withdrawal in the treatment of heroin addiction. (1972) (8)
- Epidemiologic and family studies (1984) (8)
- In situ hybridization histochemistry as a method to assess GABAAreceptor subunit mRNA expression following chronic alprazolam administration (1999) (8)
- Pharmacokinetic determinants of the response to single doses of chlordiazepoxide. (1974) (8)
- Towards an Observational Structure for Rating Dysfunction and Pathology in Ambulatory Geriatrics1 (1979) (8)
- Can lithium cause hair loss? (1983) (8)
- Responses to Psychotropic Drugs in the Normal Elderly (1973) (8)
- The psychology of hallucinogenic drug discontinuers. (1972) (8)
- Benzodiazepine hypnotic metabolism: drug interactions and clinical implications (1986) (8)
- Clinical Pharmacology and Therapeuticsof Antidepressants (2011) (8)
- Close correlation of acetaminophen clearance with that of conjugated benzodiazepines but not oxidized benzodiazepines (2004) (8)
- Management of Reactions to Disaster (1966) (8)
- Nefazodone in vitro: Metabolic conversions, and inhibition of P450‐3A isoforms (1996) (8)
- Does continuous use of fluoxetine during the first trimester of pregnancy present a high risk for malformation or abnormal development to the exposed fetus? (1992) (8)
- Some thoughts about medical caring. (2015) (8)
- Endocrine effects of psychotropic drugs: VI. Male sexual function. (1968) (7)
- Measurement of staff attitudes and the clinical course of patients on a psychiatric ward. (1966) (7)
- More on potassium, the heart, and antipsychotic agents. (1999) (7)
- More on drugs and pregnancy. (1995) (7)
- Behavioral correlates of the guessing game. Side effects and double-blind studies. (1966) (7)
- Antipyretic analgesic drugs as models for studies of drug disposition in old age. (1983) (7)
- Absolute bioavailability of imipramine: Influence of food (2004) (7)
- The importance of presystemic extraction in clinical psychopharmacology. (1996) (7)
- Psychiatrists' responses to violence: pharmacologic management of psychiatric inpatients. (1983) (7)
- Behavioral toxicity of psychotropic drugs. V. Effects on gross behavior patterns. (1969) (7)
- Selective serotonin reuptake inhibitor antidepressants: cardiovascular complications--sorting through findings. (2001) (7)
- Benzodiazepine receptor binding response to acute and chronic stress is increased in aging animals. (1991) (7)
- Pharmacotherapy and Psychotherapy (1982) (7)
- Cell-to-cell talk: plasmids and exosomes. (2014) (7)
- The psychiatrist as mind sweeper. (1982) (7)
- Emergency room study of sedative-hypnotic overdosage: a study of the issues (1982) (7)
- Behavioral treatment of enuresis nocturna. (1968) (6)
- The behavioral effects of nicotinamide adenine dinucleotide in chronic schizophrenia (2004) (6)
- Benzodiazepine overuse-misuse. (1984) (6)
- Clinical indications for plasma level monitoring of psychotropic drugs. (1979) (6)
- The antiaggressive effects of lithium in man (2004) (6)
- Problems of polypharmacy in depression. (1976) (6)
- The Impact Non-Factor. (2017) (6)
- An interactive model for panic disorders. (1984) (6)
- A BENZODIAZEPINE MOOD EFFECT SCALE: RELIABILITY AND VALIDITY DETERMINED FOR ALCOHOL-DEPENDENT SUBJECTS AND ADULTS WITH A PARENTAL HISTORY OF ALCOHOLISM (2001) (6)
- Chronic benzodiazepine administration: effects in vivo and in vitro. (1990) (6)
- The effect of chronic lorazepam administration in aging mice (2006) (6)
- Antidepressant Treatment of Geriatric Depression (2011) (6)
- Antidepressants as hydrobromide salts: are they a cause for concern? (2009) (6)
- Prenatal benzodiazepine administration. II. Lorazepam exposure is associated with decreases in [35S]TBPS binding but not benzodiazepine binding (1991) (6)
- Conflicts of interest, redundant publication, and identification of authorship: a plea for trust instead of suspicion. (1998) (6)
- Sensitivity to Triazolam in the Elderly (1992) (6)
- The Chronic Patient: Issues and Concerns???Part II (1986) (6)
- Manual of psychiatric therapeutics : practical psychopharmacology and psychiatry (1975) (6)
- Plasma and cerebrospinal fluid concentrations of chlordiazepoxide and its metabolites in surgical patients. (1977) (6)
- Separate and combined effects of caffeine and alprazolam on motor activity and benzodiazepine receptor binding in vivo (1990) (6)
- Protease inhibitors and drug interactions--an alert. (1996) (6)
- Benzodiazepines, antidepressants and addiction: A plea for conceptual rigor and consistency (2019) (6)
- Epiphenomenal, causal, or correlational--more on the mechanism(s) of action of antidepressants. (1998) (5)
- Stress and bronchitis. (1968) (5)
- The Sunshine Act (2014) (5)
- Rational psycho-pharmacology for patients with medical diseases. (1976) (5)
- Atropine overdose in three children. (1972) (5)
- Pharmacokinetics and clinical drug effects in the elderly [proceedings]. (1979) (5)
- Some Thoughts on Pharmacovigilance and Postmarketing Surveillance. (2016) (5)
- Fruit juices and pharmacology. (1997) (5)
- Pharmacokinetic Aspects of Anxiolytic Drug Therapy (1980) (5)
- Diagnosis and Drug Treatment of Psychiatric Disorders: Adults and Children, 2nd ed. Clinical Handbook of Antipsychotic Drug Therapy (1982) (5)
- Is there anything new on the use of psychotropic drugs during pregnancy? (1994) (5)
- Joining the Effort: The Challenges in Establishing Guidelines for Sex- and Gender-specific Research Design in Clinical Therapeutic Studies. (2017) (5)
- Biological Theories of Depression and Implications for Current and New Treatments (2011) (5)
- Psychopharmacology in the aged. Research considerations in geriatric psychopharmacology. (1974) (5)
- 2017, Sexual Dimorphism, Sexual Pluralism, and More. (2017) (5)
- Too good to be true? Aspirin and schizophrenia. (2012) (5)
- Population Pharmacokinetics of Methylphenidate (1999) (5)
- SIDE EFFECTS AND DOUBLE-BLIND STUDIES. I. A CLINICAL COMPARISON BETWEEN THIORIDAZINE HYDROCHLORIDE AND A COMBINATION OF PHENOBARBITAL AND ATROPINE SULFATE. (1964) (5)
- Rational use of psychotropic drugs II. Antianxiety agents. (1974) (5)
- Decreased EEG Sensitivity to Alprazolam in Subjects with a Parental History of Alcoholism (2000) (4)
- Say "no" to drug testing. (1990) (4)
- Newer antidepressants: further reflections. (1997) (4)
- The safety of over-the-counter drugs: some reflections and unanswered questions. (2003) (4)
- Diagnosis of drug and alcohol abuse (1982) (4)
- Benzodiazepines in clinical medicine: discussion. (1981) (4)
- Neurobiology of Drug Abuse. Monographs in Neural Sciences, Vol. 13 (1988) (4)
- Subjective determinants of drug prescription: a study of therapists' attitudes. (1968) (4)
- Illness Care???A Finite System? (1986) (4)
- The Breast Metaphor and the Group (1968) (4)
- Delivering Mental Healthcare: A Guide for HMOs (1988) (4)
- Saturated and trans fats. (2014) (4)
- Herpes and clinical psychopharmacology. (1987) (4)
- Cervical Cancer and Human Papilloma Virus. (2016) (4)
- Thoughts About Journals, Altruism, Impact Factors, Marijuana, and the Physician Labeling Rule. (2017) (4)
- Diazepam in the Elderly: Looking Back, Ahead, and at the Evidence. (2020) (4)
- Facts and public policy: should I keep my child on ADHD drugs? (2006) (4)
- Bioequivalence of Generic Drugs in Clinical Psychopharmacology (1987) (4)
- A patient of mine missed a period while taking fluoxetine; it turned out that she was not pregnant. However, the question arose about the safety of fluoxetine during pregnancy. What is known? (1992) (4)
- Rational use of psychotropic drugs. IV. Antidepressants. (1974) (4)
- Greetings on Our 10th and a Commentary on Redundancy in Publication (1990) (4)
- Mechanisms and Consequences of Drug–Drug Interactions (2010) (4)
- Drug interactions involving psychotropic drugs. (1978) (4)
- The PAP test and the pap smear. (2015) (4)
- Vitamin C prophylaxis and some problems of statistical inference. (1974) (4)
- Benzodiazepine sensitivity in panic disorder (1989) (4)
- Does lithium both cause and treat pseudobulbar affect? (1992) (4)
- Tybamate: an examination of its actions in "high" and "low" anxious normals. (1969) (4)
- Adherence Measurements in Clinical Trials and Care. (2018) (3)
- Case Reports and Informed Consent. (2018) (3)
- The Ten Cs of Good Clinical Care. (2016) (3)
- Pharmacokinetics of Protease Inhibitors and Drug Interactions with Psychoactive Drugs (2002) (3)
- Gerontokinetics: The Pharmacokinetics of Drugs in the Elderly (1990) (3)
- Molindone: a pilot evaluation during the premenstruum. (1975) (3)
- Psychosis and Psychotherapy. (2019) (3)
- An Anecdote About Arthritis and Boswellia serrata. (2018) (3)
- Water safety, medication disposal, and more: an update. (2010) (3)
- Can Beliefs Be Modified? (2019) (3)
- Some personal reflections on health care reform. (2008) (3)
- Chronic Low‐Dose Alprazolam Augments γ‐Aminobutyric AcidA Receptor Function (1992) (3)
- Staff-patient interaction patterns and opinions about mental illness. (1969) (3)
- Placebos and Clinical Therapeutics. (2017) (3)
- New anxiolytics: are they really new? (1982) (3)
- Rational use of psychotropic drugs. III. Major tranquilizers. (1974) (3)
- Correlation of human menstruation and lunar phase (1975) (3)
- Effect on the liver of long-term tranquilizing medication. (1965) (3)
- A new year, a new look. (2013) (3)
- Endocrine effects of psychotropic drugs. 3. Glucose metabolism. (1968) (3)
- Pharmacodynamics of benzodiazepines after single oral doses: kinetic and physiochemical correlates. (1984) (3)
- Self-rated sedation and plasma concentrations of desmethyldiazepam following single doses of clorazepate (2004) (3)
- Cardiovascular effects of psychotropic drugs. (1969) (3)
- Endocrine effects of psychotropic drugs. 1. Galactorrhea and gynecomastia. (1968) (3)
- Some current treatment options for symptoms of anxiety. (1983) (3)
- MAOIs and hypertension. (1992) (3)
- Factors influencing blood concentrations of chlordiazepoxide: A use of multiple regression analysis (1977) (3)
- Psychopharmacologic Management of Anxiety in the Cardiac Patient (1971) (3)
- Lithium and the newborn heart. (1990) (3)
- Foods, genetics, and drug interactions. (2003) (3)
- Human papillomavirus infections, more on colchicine, and some farewells and welcomes. (2014) (3)
- The cart before the horse? Health insurance reform before health care reform. (2009) (3)
- Is oxazepam associated with hostility? (1975) (3)
- Thought Disorder in Schizophrenia (1968) (3)
- Psychiatrists' biases: who get drugs? (1968) (3)
- The clinical choice of sedative-hypnotics. (1973) (3)
- Reflections on 2013, the beginning of 2014, and the Food and Drug Administration's new expedited approval program known as breakthrough product designation. (2013) (2)
- MAOIs and drug interactions--a proposal for a clearinghouse. (1985) (2)
- Kynurenine--an old pathway retraced. (2006) (2)
- Outliers--noise, nuisance, or opportunity? (1991) (2)
- A New Axis II Diagnosis: TROUBLEs (1984) (2)
- Risk Evaluation and Mitigation Strategies (REMS), Pemoline, and What Is a Signal? (2017) (2)
- Slow Accumulation and Elimination of Diazepam and Its Active Metabolite With Extended Treatment in the Elderly (2020) (2)
- Thyroid function monitoring for lithium-treated patients. (1988) (2)
- A Note from the Editor-in-Chief Emeritus: A Reluctant Farewell to Clinical Therapeutics. (2020) (2)
- Risk Factors Versus Causes. (2019) (2)
- What is depression and who is in depression studies? (2014) (2)
- Single versus repeated dosage of the minor tranquilizer chlordiazepoxide (Librium). (1972) (2)
- Placebos, Active Placebos, and Clinical Trials. (2017) (2)
- Seven Aphorisms About Therapeutic Relationships and Listening. (2019) (2)
- User unfriendly drugs--fillers, additives, excipients. (1985) (2)
- Effect of blood collection tubes on antidepressant concentrations. (1987) (2)
- Drug Safety, Climate Change, Causality, and Predictability. (2017) (2)
- Antidepressants: the second harvest and DSM-III. (1981) (2)
- The effect of social feedback on chronic schizophrenic patients. (1970) (2)
- ClinicalTrials.gov, Inhaled Loxapine, and Safety Issues. (2017) (2)
- Falls, Frailty, Vision, and Aging. (2019) (2)
- An evaluation of isoquinazepon (SAH-1123). (1967) (2)
- Welcome to a New Decade and to the Year 2000 (2000) (2)
- What do you do when a depressed patient on an antidepressant complains of impotence (1983) (2)
- A Nonpsychopharmacologic Commentary on Schizophrenia (1986) (2)
- Endocrine and metabolic effects of psychotropic drugs. IV. Hypothalamic-pituitary-adrenal axis. (1968) (2)
- Clinical Pharmacokinetics of Lorazepam II. Intramuscular Injection (1979) (2)
- Assumptions in Clinical Trial Designs and Therapies. (2018) (2)
- Zoonotic Viruses: The Mysterious Leap From Animals to Man (2018) (2)
- On guidelines for maximum dosages. (1978) (2)
- Editors' note: New Board of International Consulting Editors (BICE). (2013) (2)
- The problem of medical-psychiatric illness in the homeless and its occurrence in the midst of a viral pandemic: A commentary (2020) (2)
- In Addition to Pharmacotherapy and Psychotherapy for Psychosis, Is Anything Else Useful? (2019) (2)
- The challenge of teaching psychopharmacology and improving clinical practice. (2005) (2)
- Methaqualone abusers: a preliminary survey of college students. (1975) (2)
- Good news and disappointing news: a new era in health care delivery. (2010) (2)
- Benzodiazepine hypnotics. (1990) (2)
- Adverse effects of LSD: a current perspective. (1970) (2)
- More on Women's Health, Gender Medicine, and the Complexities of Personalized Medicine. (2016) (2)
- Bioequivalence studies in the elderly: a pilot study of two oxazepam dosage forms. (1987) (2)
- A blueberry cocktail helps with memory loss: too good to be true? (2014) (1)
- Pharmacokinetics: the view from Clinical Therapeutics. (2015) (1)
- Elements of a Good Scientific Paper (2016) (1)
- Influenza vaccines-thoughts and current status. (2013) (1)
- Actual versus reported benzodiazepine usage by medical outpatients (2004) (1)
- How Homogeneous Are Diagnostic Groups? (2021) (1)
- It's in the bag: drug absorption by drug-delivery systems. (1997) (1)
- Cardiac effects of imipramine hydrochloride in the elderly. (1975) (1)
- Superbugs, Colistin, and Related Issues. (2016) (1)
- Collagen disease-like syndrome following administration of a benzodiazepine derivative. (1967) (1)
- I read a recent report suggesting a causal relationship between a dystonic reaction in a patient and her use of sumatriptan. Is this likely? (1995) (1)
- Since my return from China, many of my colleagues have asked, ???Did you learn anything about MAOIs and Chinese foods???? (1988) (1)
- Alarmins and More. (2016) (1)
- More on Altruism, Moral Behavior, and Assent by Children for Research. (2017) (1)
- Endocrine effects of psychotropic drugs: V. Pituitary-thyroid axis. (1968) (1)
- Are any antianxiety agents safer for patients who spend a great deal of time in direct sunlight? (1992) (1)
- MedWatch, the new FDA adverse effects reporting system. (1993) (1)
- Benzodiazepines during early pregnancy. (1984) (1)
- Statistics and Evaluating the Elderly for Surgery. (2015) (1)
- Some Thoughts About Artificial Intelligence. (2019) (1)
- Discussion: sources of variance in studies of drugs and other therapies. (1976) (1)
- In Memoriam: Donald F Klein, MD. (2019) (1)
- Practice Guidelines and Lithium Levels (1992) (1)
- Misconduct in science and misconduct against scientists. (1989) (1)
- Are there times when lithium levels below the usual 0.7 to 1.2 mEq/liter range are indicated? (1982) (1)
- Drug glucuronidation in obesity (1982) (1)
- Water, water everywhere: but is it safe to drink? Return to a muddy topic. (2008) (1)
- Benzodiazepines and pregnancy--more to say and more to learn. (1989) (1)
- A Farewell, a Greeting, and a Thought about Relapses in Depression (1983) (1)
- Acetaminophen (Paracetamol), COVID-19, and Misleading Conclusions: A Commentary. (2021) (1)
- Obsessive-Compulsive Disorders, Transitions, a Welcome, a Thank You and Farewell (1984) (1)
- Mass units or molar units for drug concentration? (1999) (1)
- Alprazolam, panic disorder, and the new 2 mg tablet. (1991) (1)
- Pharmacovigilance and Some Thoughts About What We Eat. (2018) (1)
- Sea and Kosher Salts Versus Iodized Table Salt, a Reminder (2022) (1)
- Propranolol's psychiatric side effects. (1983) (1)
- In memoriam: Louis Lasagna, MD 1923-2003. (2004) (1)
- Polypharmacy, Pill Burden, and Optimizing the Medicine Cabinet. (2019) (1)
- Editors' note: retraction notice. (2014) (1)
- Sexual dysfunction associated with Mesoridazine Besylate (Serentil) (2004) (1)
- Some Reflections on Meditation and Mindfulness. (2017) (1)
- Case 7: the addled nonagenarian. (1995) (1)
- Vitamins C and D (2017) (1)
- A Tribute to Gertrude Belle Elion on the 100th Anniversary of her Birth. (2018) (1)
- The observers and the observed: the effects of doing ratings on staff-patient contact patterns. (1966) (1)
- A Mentation on Mold. (2018) (1)
- An investigation of the stimulating and mood-elevating properties of pipradol HCl administered to clinically normal volunteers. (1968) (1)
- Acute coronary syndromes, seedless watermelons, and colchicine. (2013) (1)
- Endocrine effects of psychotropic drugs. II. Amenorrhea. (1968) (1)
- SAFETY OF NITRAZEPAM (1974) (1)
- Lorazepam and oxazepam kinetics in women on lowdose oral contraceptives (1983) (1)
- Panic disorders: clinical update 1984. Epidemiologic and family studies. (1984) (1)
- Canny Cases???The Teaching Value of Vignettes (1994) (1)
- Halazepam as a precursor of desmethyldiazepam: Quantitation by electron-capture gas-liquid chromatography (2004) (1)
- Ritonavir impairs clearance and enhances toxicity of trazodone (2003) (1)
- Lung Cancer and Processing the Unknown: The Shoes of Damocles and 8 Coping Strategies. (2021) (1)
- Chronic low-dose alprazolam augments gamma-aminobutyric acid(A) receptor function. (1992) (1)
- A possible new approach to the treatment of neuroleptic malignant syndrome. (1992) (1)
- Some Reflections on the Microbiome and Obesity. (2015) (1)
- Anxiolytic drug therapy in patients with medical disease: clinical importance of pharmacokinetic drug interactions. (1984) (1)
- Rational use of psychotropic drugs. II. Antianxiety agents. (1974) (1)
- Prophylactic Vaccines, Successes, Errors, and Complications. (2017) (1)
- Ocular (pigmentary) effects of psychotropic drugs. (1970) (1)
- Are there other substances in food in addition to tyramine that can cause reactions with MAOIs (1988) (1)
- Antimicrobial stewardship. (2013) (1)
- Current Medical Diagnosis and Treatment 1982 (1982) (1)
- Diabetes, More on Merde, the Microbiome, and the Dung Beetle. (2015) (1)
- Musings on Social Media and GIST (Gastrointestinal Stromal Cancer). (2017) (1)
- Short half-life benzodiazepines. (1984) (1)
- Mental illness, pharmacotherapy, and automobile operation: what is the risk? (1992) (1)
- Health care reform. (2013) (1)
- Drug-attributed hepatic failure: causality, risk assessment, consent, and confusion. (2003) (1)
- Troublesome News, Fake News, Biased or Incomplete News. (2018) (1)
- Extrapyramidal side effects of psychotropic drugs. (1969) (1)
- Some Reflections on Sleep and its Treatment. (2016) (1)
- 1993 Physicians?? GenRx The Official Drug Reference of FDA Prescribing Information and Therapeutic Equivalents (1993) (1)
- Host-Pathogen Interactions. (2019) (0)
- Recent Advances in the Biology of Schizophrenia (1975) (0)
- Developmental Dyslexia and Learning Disorders: Diagnosis and Treatment. Child Health and Development Series, Vol. 5 (1988) (0)
- Are any antianxiety agents safer for patients who spend a great deal of time in the: sun? (1992) (0)
- A Visit to China and a Welcome to Volume 8 and 1988 (1988) (0)
- I wonder if you have any information about the safety of buspirone when used in: combination with a monoamine oxidase inhibitor (MAOI). I often use a ???generalized??? (1990) (0)
- Reflection on the Affordable Care Act (ACA) of 2010. (2014) (0)
- 55 S-59 S BENZODIAZEPINES IN CLINICAL MEDICINE : DISCUSSION CHAIRMAN : (2006) (0)
- Is there any new information since your ???Question the Experts??? in the August 1985 issue (p. 249) about the use of vitamin B6 (pyridoxine) supplementation in patients on MAOIs? (1987) (0)
- More Thoughts About Boswellia serrata. (2022) (0)
- Steady-state plasma desmethyldiazepam during long-term clorazepate use: effect of antacids (1982) (0)
- James (Jeff) Walter Jefferson, MD. (2020) (0)
- Novel Antipsychotic Drugs (1993) (0)
- Disclosures. (2019) (0)
- Reporting Currency Values; and Video Abstract Guidelines. (2018) (0)
- Newly marketed medications: ABCs and mind your Qs. (1990) (0)
- Rheumatoid arthritis and more. (2014) (0)
- Forgotten Influences and Reflections on Exercise and on the End of the Year 2017. (2017) (0)
- Drugs and Aging. Dieter Platt (editor). Springer-Verlag. Berlin, 1986, 216 pages, $35.00 (1986) (0)
- Pharmacoepidemiology. (2019) (0)
- When to drool is cool. (2015) (0)
- Are there natural food sources available for patients who take MAOIs and who: require supplemental vitamin B6? (1985) (0)
- How Patients Describe Their Depressions: D Words. (2021) (0)
- Reflections on Regenerative Medicine. (2018) (0)
- The separation of panic and agoraphobia from other anxiety disorders: Introduction to the conference proceedings (1988) (0)
- Nomifensine--a farewell and future concerns. (1986) (0)
- Diagnosis and Treatment of Depression During Pregnancy and Lactation (2004) (0)
- Thinking while balancing: what to do about replacing dropouts. (1994) (0)
- The Prudent Use of Medicines (1982) (0)
- A brief commentary on the Boston State Hospital case. (1980) (0)
- More thoughts about Phase I trials. (2014) (0)
- EDITORIAL: Authorship and Coauthorship—Working out the Meaning (1987) (0)
- Musings on Melanoma. (2019) (0)
- Pharmacokinetics of benzodiazepine hypnotics. (1983) (0)
- Suggestions for treating drug abusers in a family practice. (1974) (0)
- Drugs, populations, and type II diabetes mellitus. (2014) (0)
- The chronic patient: issues and concerns. (1985) (0)
- The Child Molester. An Integrated Approach Evaluation and Treatment (1989) (0)
- In Memorium-Martin M. Katz, PhD (1927-2017). (2017) (0)
- Does cigarette smoking by patients affect the assessment of extrapyramidal side effects secondary to antipsychotic (neuroleptic) agents (1984) (0)
- How important is it to assess thyroid function in patients with depressive symptomatology? (1981) (0)
- Faculty List for Tufts CSDD 2016 Annual Postgraduate Course in Clinical Pharmacology Drug Development, and Regulation (2016) (0)
- Further Thoughts about Opioids and Cannabinoids. (2019) (0)
- Reflections on Oncotherapies. (2018) (0)
- Baby Fat or a Fat Baby? (2018) (0)
- Confirmed Faculty Listing for Tufts CSDD's 2014 Annual Postgraduate Course in Clinical Pharmacology Drug Development, and Regulation (2014) (0)
- What are the Food and Drug Administration (FDA) requirements for identifying drug interactions when a drug is being developed for marketing in the United States (1994) (0)
- Reflections on the Phases of the Moon and the Phases of Drug Development. (2017) (0)
- Canny cases. Case 4: A precipitate poisoning. (1995) (0)
- Is There Always a Right or Wrong?: Comments on the FDA Warnings About Triptans and the Serotonin Syndrome. (2018) (0)
- Menarcheal Age and Personality: The Choice of a Statistical Test of Relationship (1974) (0)
- Clozapine--a perspective. Accepted as a consensus statement by the ACNP Council, August 13, 1990. (1991) (0)
- INFECTIOUS DISEASE UPDATE: OUTBREAK MANAGEMENT Editorial 2400 Outbreak Management (2015) (0)
- Pediatric drug shortages: a deplorable fact and a political problem. (2014) (0)
- Long term therapy of chronic schizophrenia; a reply by the authors. (1967) (0)
- Informed Consent and Assent in Pediatric Oncology Trials. (2017) (0)
- Genomics and the Prediction and Characterization of Cancer and Some Observations About Pancreatic Cancer. (2016) (0)
- Are any psychoactive medications problematic for patients sensitive to sulfites (1990) (0)
- with the highly significant reduction in clearance of the oxidized benzodiazepine diazepam. (1982) (0)
- The Placenta and Psychiatry? (2021) (0)
- The Use of Generic Drugs in Pediatric Psychopharmacology (2012) (0)
- The Patient Protection and Affordable Care Act: politics and pills. (2015) (0)
- Case 3: The Vellicating Valetudinarian (1995) (0)
- Comprar Pharmacotherapy Of Depression + Cd-Rom | Ciraulo, Domenic A. | 9781603274340 | Humana Press (2010) (0)
- Nutrition and Behavior (1983) (0)
- A Case of Inhalation Psychosis (1968) (0)
- Drs. Shader and Greenblatt Reply (1971) (0)
- A patient recently became mildly hypertensive and complained of a headache for 10 hours after taking HELP to curb the weight gain she was having on phenelzine. I found nothing in the PDR. Is this common (1985) (0)
- Phenylpropanolamine, and the Completionof Volume 2 (1982) (0)
- Concomitant estrogen use has been alleged to increase the side effects of certain oxidatively-metabolized psychiatric drugs. Are there any estrogen-free oral contraceptives (OCs)? (1989) (0)
- Serious Depression. Films for the Humanities & Sciences (1994) (0)
- An Introduction to Psychopharmacology (1973) (0)
- Neurological Clinical Pharmacology (1981) (0)
- Editor's Note: Robert A. Cohen, MD (2010) (0)
- Is activated charcoal helpful in the treatment of overdosages (ODs) with tricyclic antidepressants (TCAs)? (1986) (0)
- Can elderly nursing home patients with involuntary grimacing and vocalization be helped with psychopharmacological agents? (1984) (0)
- Editors’ Note Regarding Publication Delay (2014) (0)
- On top of atopy. (2013) (0)
- Health Secrets of Medicinal Herbs: Medical Benefits and Uses Fully Explained (1982) (0)
- Drug administration schedules. (1971) (0)
- Some observations about atrial fibrillation. (2014) (0)
- More on Antimicrobial Resistance, Linezolid, and Treating Special Populations. (2016) (0)
- In your experience with patients with panic disorders, do you give antianxiety agents regularly or as needed, and what is the longest time you keep them on medications (antianxiety and antidepressant)? (1982) (0)
- Pharmacogenetics in Psychiatry (1983) (0)
- Can antidepressants cause symptoms that resemble the neuroleptic malignant syndrome (NMS) (1984) (0)
- What psychotropic drugs are now available in generics (1987) (0)
- More Reflections on Obesity. (2015) (0)
- In Memoriam: Frederick King Goodwin (1936-2020). (2020) (0)
- 11th European association for clinical pharmacology and therapeutics congress, 2013. (2013) (0)
- I have heard that buspirone regularly affects various blood tests. Is this so? (1996) (0)
- You have previously commented on the possibility of seizures with maprotiline. What about the other newer antidepressants (1984) (0)
- Some Reflections on Diabetes Mellitus. (2016) (0)
- Cancer in the Elderly. (2018) (0)
- CLINICAL PHARMACOKINETICS OF LORAZEPAM 4, LONG-TERM ORAL ADMINISTRATION (1978) (0)
- Clinical Toxicology of Commercial Products (1985) (0)
- Can lithium or tryptophan be safely combined with selective serotonin uptake inhibitors (1990) (0)
- Drug therapy. Current status of benzodiazepines. (1983) (0)
- Rational use of psychotropic drugs. IV. Antidepressants. (1974) (0)
- What can be done for depression following acute schizophreniform psychosis? (1981) (0)
- Back to basics--diagnosis before treatment: homelessness, hypothyroidism, aging, and lithium. (1987) (0)
- "Look-alikes" and generics. (1986) (0)
- In Memoriam: Bernard J. Carroll, MD, PhD. (2018) (0)
- Water-suppressed proton nuclear magnetic resonance spectroscopy of plasma from schizophrenics and normal controls: A preliminary report (1992) (0)
- Heart failure: new approaches to an old problem. (2015) (0)
- Symposia—An Evolving Policy (1981) (0)
- A Farewell to Arms, to Staff, to You, and to the Journal of Clinical Psychopharmacology. (2020) (0)
- Amoxapine, an observation, and a perspective on MAOIs and their safety. (1981) (0)
- Chlordiazepoxide and Hostility (2015) (0)
- Subject Index, Vol. 27 (Suppl 2), 1983 (1983) (0)
- Anniversaries, Goodbyes, and Poisons???Life Goes On (1983) (0)
- Access to Clinical Therapeutics. (2015) (0)
- Draft legislation: the Science Research Protection Act of 1990. (1990) (0)
- Some Observations on the Problem of Anxiety (2019) (0)
- Yawning, a Postscript and Preliminary Thoughts about Sighing (1987) (0)
- The verdant octogenarian. (1994) (0)
- Case 8: the wambly sophomaniac. (1995) (0)
- "Inflamma" and Other "Somes". (2019) (0)
- Preliminary experiences with the treatment of opiate addiction by methadone withdrawal. (1972) (0)
- Drugs in the management of anxiety. (1971) (0)
- The concept and phenomenology of depression, with special reference to the aged. Discussion. (1974) (0)
- Factors influencing variability in clinical trials and in individuals' responses to treatment. (2013) (0)
- "Dem" back and neck and hand and knee and hip bones: pain and aging. (2013) (0)
- Book ReviewClinical Psychopharmacology. (1978) (0)
- Women and Heart Disease. (2019) (0)
- The liver: a vulnerable helper. (2013) (0)
- Training in Psychosomatic Medicine (Vol. 5-Advances in Psychosomatic Medicine) (1969) (0)
- Reports on past meetings (1982) (0)
- When old ways no longer work: antibiotics and drug development. (2014) (0)
- Cancer chemotherapy: a rapidly moving train. (2013) (0)
- Some Comments on Infection Prophylaxis. (2015) (0)
- Kinetic anddynamic interaction ofbrotizolam andethanol (1986) (0)
- Statistical Versus Clinical Significance: A Question About Caplyta (Lumateperone). (2022) (0)
- The Mitchell B. Balter Award for Research in Pharmacoepidemiology and Pharmacotherapy (1995) (0)
- Case 6: a free solution. (1995) (0)
- Lithium nephropathy and antipyretic analgesics--an uncontrolled variable. (1989) (0)
- Errors in science versus scientific fraud. (1989) (0)
- Untreated Mental Illness Has Created a National Tragedy: A Pandemic of Homelessness. (2022) (0)
- Anxious Depression: Assessment and Treatment (1988) (0)
- Dr. Appelbaum and Associates Reply (1983) (0)
- Associations About Arthritis. (2019) (0)
- Editor's note: Clinical trial designs and statistics made easy. (2014) (0)
- Comparative effects of single and repeat dose administration of antianxiety agents. (1971) (0)
- Some thoughts on a new antidepressant and a marking of the death of John Cade, MD. (1981) (0)
- Comments on Watson, the Microbiome of Children, and Patient-reported Outcomes. (2016) (0)
- Drug therapy reviews: rational use of psychotropic drugs. III. Major tranquilizers. (1974) (0)
- Recent Recall of a Generic Form of Extended-Release Paliperidone. (2017) (0)
- Editorial manager (Ed Mr.) and not Mr. Ed (2003) (0)
- Treating the drug abuser in the ED. (1975) (0)
- Comments on Chronic Fatigue Syndrome. (2019) (0)
- Urgent pharmacotherapy for drug abuse. (1975) (0)
- Response to the Letter to the Editor. (2017) (0)
- Shades of the patent medicine man. (1983) (0)
- COVID19 and Depression (2020) (0)
- Sex versus gender: a touchy subject for multiple sclerosis. (2014) (0)
- Worry dissected. (2015) (0)
- Letter: Correlation of human menstruation and lunar phase. (1975) (0)
- The Council on Medical Education and Career Development (1976) (0)
- Case 2: Dizzy Giuseppi or the vertiginous virtuoso. (1994) (0)
- Canny cases. Case 5: the dextral dodder. (1995) (0)
- Some Reflections on Hypertension and Its Treatment. (2016) (0)
- Some Reflections on Neuropathies. (2017) (0)
- Discontinue after last dose--an editorial and information about prescription writing. (2002) (0)
- Clinical Handbook of Antipsychotic Drug Therapy (1981) (0)
- My Kingdom for a Denominator, or at Least Enough Data (2020) (0)
- Book ReviewHandbook of Lithium Therapy (1981) (0)
- Drugs Five Years Later (2020) (0)
- Some Thoughts About Racial Disparities. (2017) (0)
- In Memoriam: Eberhard Henry Uhlenhuth, MD (1928-2016). (2016) (0)
- Letter: Safety of nitrazepam. (1974) (0)
- Book ReviewPsychopharmacology of Affective Disorders (1979) (0)
- What antidepressant do you choose in cardiac patients with panic attacks (1982) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Richard I. Shader?
Richard I. Shader is affiliated with the following schools:
